Similar articles

• Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

  Gerich JE, Lorenzi M, Schneider V, Karam JH, Rivier J, Guillemin R, Forsham PH. Gerich JE, et al. N Engl J Med. 1974 Sep 12;291(11):544-7. doi: 10.1056/NEJM197409122911102. N Engl J Med. 1974. PMID: 4604408 Clinical Trial. No abstract available.
• Editorial: Somatostatin: newcomer from the hypothalamus.

  Brazeau P, Gullemin R. Brazeau P, et al. N Engl J Med. 1974 Apr 25;290(17):963-4. doi: 10.1056/NEJM197404252901711. N Engl J Med. 1974. PMID: 4206096 No abstract available.
• [Glucagon and diabetes].

  Taskinen MR. Taskinen MR. Duodecim. 1976;92(9):455-7. Duodecim. 1976. PMID: 776583 Finnish. No abstract available.
• Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.

  Cryer PE, Gerich JE. Cryer PE, et al. N Engl J Med. 1985 Jul 25;313(4):232-41. doi: 10.1056/NEJM198507253130405. N Engl J Med. 1985. PMID: 2861565 Review.
• [Is there a possible role of a growth hormone hypersecretion in the course of the vascular complications of diabetes mellitus?].

  Lundbaek K. Lundbaek K. Journ Annu Diabetol Hotel Dieu. 1972;13(0):161-72. Journ Annu Diabetol Hotel Dieu. 1972. PMID: 4605760 Review. French. No abstract available.